Schlapbach et al. investigated the role of the IL-23/Th17 pathway in HS utilizing semiquantitative real-time polymerase chain reaction (RT-PCR) and immunohistochemistry (IHC), reporting a high expression of both IL-23 and IL-17 in HS lesions. Here, IL17A is linked to histiocytic sarcoma.